<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="26995">Thromboxane</z:chebi> (Tx)B2 and 6-keto-<z:chebi fb="11" ids="26333">prostaglandin</z:chebi> (6-keto-PG) F1 alpha formation in the hippocampus and caudate nucleus were evaluated by microdialysis during and following forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Spontaneously hypertensive rats were subjected to bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> with simultaneous <z:hpo ids='HP_0002615'>hypotension</z:hpo> for 8, 14, or 20 min </plain></SENT>
<SENT sid="2" pm="."><plain>Dialysate was collected during the ischemic interval and during the reperfusion period </plain></SENT>
<SENT sid="3" pm="."><plain>TxB2 and 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi> levels were measured by radioimmunoassay </plain></SENT>
<SENT sid="4" pm="."><plain>In both structures, TxB2 production increased significantly during the reperfusion period in <z:hpo ids='HP_0000001'>all</z:hpo> three ischemic groups </plain></SENT>
<SENT sid="5" pm="."><plain>By contrast, increased 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi> elaboration was observed after only the longest ischemic duration </plain></SENT>
<SENT sid="6" pm="."><plain>While TxB2 levels gradually decreased during the 3-h reperfusion period in <z:hpo ids='HP_0000001'>all</z:hpo> groups, the levels in the group subjected to 8 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> returned to control values most rapidly </plain></SENT>
<SENT sid="7" pm="."><plain>A relationship between the duration of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and TxB2 production was therefore evident </plain></SENT>
<SENT sid="8" pm="."><plain>6-Keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi> levels increased in only the group subjected to 20 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and, by contrast to the pattern of TxB2 change, 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi> levels remained elevated throughout the reperfusion period </plain></SENT>
<SENT sid="9" pm="."><plain>During reperfusion, the ratio of TxB2 to 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi> increased substantially versus the preischemic period in both structures </plain></SENT>
<SENT sid="10" pm="."><plain>The data demonstrate that eicosanoid elaboration following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> can be evaluated by the microdialysis technique </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, they indicate that the thresholds (duration of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) for the postischemic production and the temporal profiles of TxB2 and 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi> in the caudate and hippocampus differ </plain></SENT>
<SENT sid="12" pm="."><plain>They also demonstrate that there is regional <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in the patterns of eicosanoid elaboration after forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>